Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Unknown 2

Sponsor Class

OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Surgical Wound Infection 2Adenomatous Polyposis Coli 2Wounds and Injuries 1Waldenstrom Macroglobulinemia 1Surgical Wound 1Stomach Neoplasms 1Rectal Neoplasms 1Ras-wildtype Colorectal Cancer 1Polyps 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Eyelid Diseases 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Celecoxib 7Biopsy 5Sulindac 4Specimen Handling 3Eflornithine 3Curcumin 3guselkumab 2Ursodeoxycholic Acid 2Surveys and Questionnaires 2Sirolimus 2Sigmoidoscopy 2Gastroscopy 2Erythromycin 2Erlotinib Hydrochloride 2Endoscopy, Gastrointestinal 2Endoscopy, Digestive System 2Endoscopy 2Colonoscopy 2trifluridine tipiracil drug combination 1rofecoxib 1obeticholic acid 1Thiamine 1Surgical Procedures, Operative 1Suppositories 1Probiotics 1Polymorphism, Single-Stranded Conformational 1Polymerase Chain Reaction 1Pharmaceutical Preparations 1Oxaliplatin 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Adenomatous Polyposis Coli × Erythromycin × Clear all
NCT02354560 2015-02-03

Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown
15 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

NCT02175914 2014-06-26

Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown
20 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon âš¡